Literature DB >> 7042954

The effects of immunosuppressive drugs on periodontal inflammation in human renal allograft patients.

V Been, D Engel.   

Abstract

The periodontal status of four kidney allograft patients was determined before and at periodic intervals for 9 months after receipt of the allografts. These patients received immunosuppressive drugs as part of their therapy, beginning at the time of transplantation. Three hemodialysis patients with analogous kidney disease and six eye patients who were otherwise healthy served as controls. Comparisons of plaque levels, pocket depths and gingival inflammation were made between the three groups of subjects. The results suggest that the administration of the immunosuppressive drugs significantly reduces the level of gingival inflammation in the presence of high levels of bacterial plaque. Pocket depths did not change significantly in eigher the allograft or control groups. Whole not conclusive, the findings support the hypothesis that host inflammatory and immunological responsiveness to plaque bacteria is a primary factor in the pathogenesis of destructive periodontal disease in humans.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042954     DOI: 10.1902/jop.1982.53.4.245

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  8 in total

1.  Periodontitis treatment improves systemic lupus erythematosus response to immunosuppressive therapy.

Authors:  Cristiana Fabbri; Ricardo Fuller; Eloisa Bonfá; Lissiane K N Guedes; Paulo Sergio R D'Alleva; Eduardo F Borba
Journal:  Clin Rheumatol       Date:  2014-01-11       Impact factor: 2.980

2.  CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice.

Authors:  P J Baker; M Dixon; R T Evans; L Dufour; E Johnson; D C Roopenian
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

3.  Periodontal bone loss and immune characteristics of congenitally athymic and thymus cell-reconstituted athymic rats.

Authors:  H Yoshie; M A Taubman; J L Ebersole; D J Smith; C L Olson
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

Review 4.  Is periodontal disease preventable?: a review.

Authors:  J D Manson; I M Waite
Journal:  J R Soc Med       Date:  1983-05       Impact factor: 18.000

5.  Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status.

Authors:  Jôice Dias Corrêa; Débora Cerqueira Calderaro; Gilda Aparecida Ferreira; Santuza Maria Souza Mendonça; Gabriel R Fernandes; E Xiao; Antônio Lúcio Teixeira; Eugene J Leys; Dana T Graves; Tarcília Aparecida Silva
Journal:  Microbiome       Date:  2017-03-20       Impact factor: 14.650

6.  Association of time under immunosuppression and different immunosuppressive medication on periodontal parameters and selected bacteria of patients after solid organ transplantation.

Authors:  G Schmalz; L Berisha; H Wendorff; F Widmer; A Marcinkowski; H Teschler; U Sommerwerck; R Haak; O Kollmar; D Ziebolz
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-05-01

7.  The Effects of Prednisone/Ketoprofen Administration in Association with Amoxicillin Clavulanate Following Periodontal Surgical Therapy in Patients with Severe Chronic Periodontitis.

Authors:  Lidia Sfetcu; Andreea Cristiana Didilescu; Cristian Vlădan; Octavian Dincă; Daniela Miricescu; Gabriela Băncescu; Alexandru Bucur; Laura Carina Tribus
Journal:  Medicina (Kaunas)       Date:  2021-05-04       Impact factor: 2.430

Review 8.  Periodontitis Impact in Interleukin-6 Serum Levels in Solid Organ Transplanted Patients: A Systematic Review and Meta-Analysis.

Authors:  Vanessa Machado; João Botelho; Joana Lopes; Mariana Patrão; Ricardo Alves; Leandro Chambrone; Gil Alcoforado; José João Mendes
Journal:  Diagnostics (Basel)       Date:  2020-03-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.